APPLICATION
ANDA202073
TYPE
ANDA
ORIGINAL APPROVAL
2022-09-29
LATEST ACTION
2023-11-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval), Prescription
Products
DARUNAVIRNone (Tentative Approval)
DARUNAVIR 800MG · TABLET · ORAL
DARUNAVIRNone (Tentative Approval)
DARUNAVIR 400MG · TABLET · ORAL
DARUNAVIRPrescription
DARUNAVIR 800MG · TABLET · ORAL
DARUNAVIRNone (Tentative Approval)
DARUNAVIR 600MG · TABLET · ORAL
DARUNAVIRNone (Tentative Approval)
DARUNAVIR 300MG · TABLET · ORAL
DARUNAVIRPrescription
DARUNAVIR 600MG · TABLET · ORAL
Approval history
2023-11-19Labeling · Supplement 2 · standardAP
2023-11-19Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.